Berbamine Enhances the Antineoplastic Activity of Gemcitabine in Pancreatic Cancer Cells by Activating Transforming Growth Factor-β/Smad Signaling

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Berbamine inhibits proliferation and induces apoptosis of KU812 cells by increasing Smad3 activity

(2011) Yun Liang et al.   Journal of Zhejiang University-SCIENCE B

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

A Novel Calmodulin Antagonist O-(4-Ethoxyl-Butyl)-Berbamine Overcomes Multidrug Resistance in Drug-Resistant MCF-7/ADR Breast Carcinoma Cells

(2010) Rong Liu et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Transforming Growth Factor-β Suppressed Id-1 Expression in a smad3-Dependent Manner in LoVo Cells

(2009) Hongjiang Song et al.   Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology

The Antiproliferation Effect of Berbamine on K562 Resistant Cells by Inhibiting NF-κB Pathway

(2009) Yan-Lin Wei et al.   Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology

Gefitinib Inhibits the Proliferation of Pancreatic Cancer Cells via Cell Cycle Arrest

(2009) Xiaohua Zhou et al.   Anatomical Record-Advances in Integrative Anatomy and Evolutionary Biology

Potentiation of the effect of gemcitabine by emodin in pancreatic cancer is associated with survivin inhibition

(2009) Qingqu Guo et al.   BIOCHEMICAL PHARMACOLOGY

Suppression of human lung cancer cell growth and migration by berbamine

(2009) Huiying Duan et al.   CYTOTECHNOLOGY

Adenosquamous carcinoma of the pancreas harbors KRAS2, DPC4 and TP53 molecular alterations similar to pancreatic ductal adenocarcinoma

(2009) Jonathan R Brody et al.   MODERN PATHOLOGY